Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Generic clonazepam approved

Sep. 20, 1996

Forest prepares NDA submission for antidepressant

Sep. 20, 1996

Hoechst Marion Roussel reports new antidepressants

Sep. 20, 1996

Fluphenazine ANDA approval

Sep. 20, 1996

New dopamine D4 receptor antagonists from Taisho and Nihon Nohyaku

Sep. 20, 1996

Anxiolytic/antidepressant approved in Japan

Sep. 20, 1996

Mitochondrial benzodiazepine receptor (MBR) ligands as potential anxiolytics

Sep. 20, 1996

Glaxo Wellcome identifies potential anxiolytic agents

Sep. 20, 1996

New CNS agents from American Cyanamid

Sep. 20, 1996

American Home Products investigates 5-HT1A antagonists for anxiety

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...